Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied
Emerging medications like retatrutide may eventually surpass all current options, and the precise dosing comparisons between medications help clinicians optimize individual treatment plans
W.BackT
R.BennettG
That does not mean intranasal delivery is impossible or unexplored
Because only one study focused on lithium, we conducted a sensitivity analysis to include only studies of N -acetylcysteine, using meta-regression to evaluate the following potential confounding factors: (1) mean age (years), (2) diagnosis (OCD or OCD-related disorders), (3) study duration (in weeks), (4) total number of individuals, and (5) percentage of female participants